Advertisement
A bipartisan Senate bill that would curb prescription drug costs is being backed by the Trump administration as a new poll shows that many Americans think the White House has done little to tackle the issue.

Bipartisan Bill to Curb Drug Costs Backed by White House

0
Senate bill does not give Medicare bargaining power but would cap out-of-pocket payments by beneficiaries
Predictors of attaining low-density lipoprotein cholesterol and systolic blood pressure goals have been identified

AHA: Predictors for Meeting LDL-C, SBP Goals ID’d in ISCHEMIA

0
Older age, male sex, high-intensity statin use, lower baseline LDL-C predict LDL-C goal attainment
The generic valsartan recall has had population-level impacts on patients in Ontario

AHA: Impact of Valsartan Recall Examined for Ontario, Canada

0
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
Patients with recent myocardial infarction have a lower risk for ischemic cardiovascular events with colchicine versus placebo

AHA: Risk for Ischemic CV Events Lower With Colchicine After MI

0
Risk for composite efficacy end point reduced with colchicine versus placebo after myocardial infarction
Childhood vaccination with the bacille Calmette-Guérin vaccine is associated with a reduced risk for lung cancer

Common TB Vaccine Associated With Lower Lung Cancer Rates

0
In 60-year follow-up, significantly lower lung cancer rates seen for those with childhood BCG vaccination
The safety of the 9-valent human papillomavirus vaccine has been confirmed

Studies Confirm Safety of 9-Valent HPV Vaccination

0
Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites
A high proportion of patients with atherosclerotic cardiovascular disease do not achieve recommended low-density lipoprotein cholesterol goals

AHA: Many With Atherosclerotic CVD Not Meeting LDL-C Goals

0
Of those patients receiving only a statin, 67.0 percent did not achieve recommended LDL-C goal
Progress has been made in slowing antibiotic resistance-associated deaths

Some Progress Made in Slowing Antibiotic Resistance-Linked Deaths

0
Deaths decreased 18 percent since 2013 report, but more than 2.8 million infections occur each year
The checkpoint inhibitor pembrolizumab prolongs survival in patients with certain head and neck cancers

Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer

0
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
For patients with chronic hepatitis C infection

Treatment Response Rates High for Seniors With Hep C Infection

0
Sustained virologic response rates similar for patients 65 years and older, patients younger than 65 years